Imcivree

Imcivree Coupons & Savings Card – Discount Prices from $3617.11

Imcivree (setmelanotide) is an injectable medication designed for long-term weight management in individuals aged 6 and older who have specific rare genetic conditions. It is particularly aimed at those with obesity linked to Bardet-Biedl syndrome (BBS) or deficiencies in POMC, PCSK1, or the leptin receptor (LEPR). This medication functions as a melanocortin agonist, targeting receptors in the brain to help reduce appetite and increase energy expenditure. Administered under the skin once daily, Imcivree assists in controlling hunger and boosting the body's calorie burn. Users should be aware of potential side effects such as injection site reactions, nausea, and, in more serious cases, depression and suicidal thoughts. Always consult with a healthcare professional for personalized guidance and advice prior to starting this treatment.
Our Imcivree coupons are free to use. You can print the coupon, email it to yourself, or receive the Imcivree coupon via text message. To get your free discount, show the pharmacist your Imcivree savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Imcivree prices will update based on your prescription needs. Above our Imcivree coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Imcivree savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

1ML of 10MG/ML, Imcivree (1 Vial)

Select pharmacy

Pharmacy logo

Rite Aid

$3617.11

COUPON PRICE
Pharmacy logo

Albertsons

$3679.29

COUPON PRICE
Pharmacy logo

Walgreens

$3736.09

COUPON PRICE
Pharmacy logo

Walmart

$3764.67

COUPON PRICE

Imcivree savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$3617.11

BIN

ID

PCN

GRP

019876

LH74FFEC7F

CHIPPO

LHX

Powered by

This card is not insurance

Related melanocortin receptor agonists prescriptions

coupons from$214.3Save 76%
coupons from$1488101.38 

More prescriptions for weight loss

coupons from$6.54Save 81%
coupons from$7.34Save 76%
coupons from$103.92Save 82%
coupons from$212.2Save 74%
coupons from$83.67Save 86%
coupons from$229.31Save 73%
coupons from$626.63Save 72%
coupons from$103.92Save 82%

Related melanocortin receptor agonists prescriptions

Vyleesi Save 76%coupons from $214.3
Scenessecoupons from $1488101.38

More prescriptions for weight loss

Phentermine Hcl Save 81%coupons from $6.54
Phendimetrazine Save 76%coupons from $7.34
Phentermine-topiramate Save 82%coupons from $103.92
Orlistat Save 74%coupons from $212.2
Methamphetamine Save 86%coupons from $83.67
Evekeo Odt Save 73%coupons from $229.31
Adzenys ER Save 72%coupons from $626.63
Qsymia Save 82%coupons from $103.92

Imcivree dosage forms

The average cost for 1 Vial of Imcivree at 1ML of 10MG/ML is $3694.06 with a free coupon. This is 72% off the average retail price of $13044.53
DosageQuantityPrice fromPer unit
1ML of 10MG/ML1 Vial$3617.11$3617.11

Imcivree Warnings

The medication Imcivree (setmelanotide) has several important safety warnings that users should be aware of. It is crucial to understand these risks and discuss any concerns with your healthcare provider. Below are the key warnings associated with this medication:

  • Sexual Function Issues: Some individuals may experience sexual problems, including unexpected penile erections in males and unwanted sexual arousal in females. If these occur, consult your prescriber. Seek immediate medical assistance if an erection lasts longer than four hours, as this could lead to permanent damage.

  • Mental Health Concerns: Imcivree (setmelanotide) may cause or exacerbate depression and suicidal thoughts or behaviors. Notify your prescriber promptly if you or those around you observe any mood or behavior changes or if you have thoughts of self-harm. Patients with a history of depression or suicidal thoughts are at a higher risk and may need to discontinue the medication.

  • Allergic Reactions: Although uncommon, allergic reactions can occur, usually within minutes to hours after an injection. Symptoms like difficulty breathing, throat tightness, or swelling of the face or tongue require immediate medical attention.

  • Skin Darkening (Hyperpigmentation): This medication may cause darkening of the skin or moles, which typically resolves after discontinuation. Regular full-body skin examinations by your healthcare provider are recommended before and during treatment to monitor for new skin spots.

  • Serious Risks to Newborns and Low Birth Weight Infants: The preservative benzyl alcohol in Imcivree (setmelanotide) can cause severe, life-threatening reactions in newborns, such as "gasping syndrome," which impacts brain function, blood acidity, and breathing. Therefore, this medication should not be used in newborns or young infants.

Always consult with your healthcare provider for personalized medical advice and before making any changes to your medication regimen.

Imcivree Side Effects

When taking this medication, some common side effects may include mild reactions at the injection site, such as redness, itching, swelling, or pain. Additionally, you might experience skin discoloration, nausea, headache, diarrhea, stomach pain, back pain, tiredness, vomiting, and unplanned penile erections. Though these effects are generally mild, consult your healthcare provider if they persist or worsen.

Other side effects that have been noted include joint pain, weakness, dizziness, dry mouth, dry skin, trouble sleeping, vertigo, hair loss, chills, constipation, flu-like symptoms, muscle spasms, pain in your arms or legs, and rash. It's advisable to inform your healthcare provider if you encounter any of these symptoms.

Certain side effects are rare but serious and warrant immediate medical attention. These include severe depression, suicidal thoughts, and prolonged erections lasting more than four hours. Additionally, a severe allergic reaction may occur, characterized by trouble breathing, swallowing difficulties, a rapid heartbeat, or swelling of the face, lips, tongue, or throat. If you experience any of these severe symptoms, seek urgent medical care. Always stay informed about potential side effects and communicate any concerns with your healthcare provider.

Imcivree FAQs
Is imcivree the same as wegovy?

Imcivree and Wegovy are not the same. Imcivree (setmelanotide) is used for chronic weight management in patients with certain rare genetic conditions, while Wegovy (semaglutide) is used for chronic weight management in adults with obesity or overweight with at least one weight-related condition. They have different active ingredients and mechanisms of action.

Imcivree is used to treat chronic weight management in patients with obesity due to certain genetic conditions, specifically those related to POMC, PCSK1, or LEPR deficiencies. It works by targeting the melanocortin-4 receptor pathway, which is involved in regulating hunger and energy expenditure.

Yes, Imcivree (setmelanotide) is approved by the FDA. It is indicated for chronic weight management in patients with certain rare genetic conditions that lead to obesity.

Imcivree (setmelanotide) is indicated for chronic weight management in patients with obesity due to certain genetic conditions. The criteria for its use include:1. Genetic Confirmation: The patient must have a confirmed diagnosis of obesity due to POMC, PCSK1, or LEPR deficiency, or Bardet-Biedl syndrome, as determined by genetic testing.2. Age Requirement: It is approved for use in patients aged 6 years and older.3. Weight Management: It is intended for chronic weight management and should be part of a comprehensive weight management program that includes dietary and lifestyle modifications.4. Monitoring: Regular monitoring of weight and other health parameters is necessary to assess the effectiveness and safety of the treatment.These criteria ensure that Imcivree is used appropriately in patients who are most likely to benefit from its effects.

The amount of weight loss on Imcivree (setmelanotide) can vary depending on the individual and the specific genetic condition being treated. In clinical trials, patients with certain genetic obesity disorders experienced significant weight loss. For example, individuals with POMC or LEPR deficiency had an average weight loss of around 10% to 25% of their initial body weight. However, results can differ based on individual factors and adherence to the treatment plan. It is important for patients to discuss their specific situation and potential outcomes with their healthcare provider.